期刊
CURRENT PHARMACEUTICAL BIOTECHNOLOGY
卷 15, 期 10, 页码 916-926出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389201015666140909150033
关键词
Agonist/antagonist mechanism; agonist-induced signaling mechanism; computer-aided drug design; dopamine receptor; Schizophrenia; serotonin receptor
资金
- National Natural Science Foundation of China [81172919, 81473136, 31400624]
- State Key Laboratory of Drug Research
- National Drug Innovative Program [2009ZX09301-011]
As the largest family of integral membrane proteins, G-protein-coupled receptors (GPCRs) comprise the largest class of therapeutic targets that aimed approximately 40% of modern medicinal drugs. Understanding the agonist/antagonist mechanism, as well as the signal transduction of the GPCRs, is pivotal in drug discovery and new therapeutic strategy development. In the past few years, determination of high-resolution crystal structures of GPCRs from different subfamilies laid a solid foundation for both experimental and computational studies on GPCR-related diseases. Dopamine and serotonin receptors that belong to class A GPCRs play key roles in psychotic disorders, such as schizophrenia. As a robust approach, computer-aided drug design (CADD) has been demonstrated to be a powerful tool to discover novel drugs against these disorders and to help understand the activation mechanism of related receptors. Herein, we reviewed the recent progresses on CADD-based drug discovery, agonist/antagonist mechanism, and agonist-induced signaling mechanism in dopamine and serotonin receptors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据